Research Article
Primary Angiosarcoma of the Breast: A 20-Year Single-Institution Experience in China
Table 2
Treatment data for 16 patients with primary angiosarcoma of the breast.
| | | Total (n = 16) | | n | % |
| | Type of surgery | | Modified radical mastectomy | 9 | 56.25 | | Simple mastectomy | 4 | 25.00 | | Tumor resection | 2 | 12.50 | | Wide excision | 1 | 6.25 | | Incisal condition | | R0 | 9 | 56.25 | | R1 | 4 | 25.00 | | Unknown | 3 | 18.75 | | Axillary lymph node dissection | | ALND | 9 | 56.25 | | SLNB | 2 | 12.50 | | No dissection | 5 | 31.25 | | Adjuvant therapy | | Chemotherapy | 8 | 50.00 | | Chemotherapy + radiotherapy | 4 | 25.00 | | Lapatinib | 1 | 6.25 | | No adjuvant therapy | 2 | 12.50 | | Unknown | 1 | 6.25 |
|
|
ALND, axillary lymph node dissection; SLNB, sentinel lymph node biopsy.
|
